Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/14449
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Boonsri P. | |
dc.contributor.author | Kuno M. | |
dc.contributor.author | Hannongbua S. | |
dc.date.accessioned | 2021-04-05T03:34:50Z | - |
dc.date.available | 2021-04-05T03:34:50Z | - |
dc.date.issued | 2011 | |
dc.identifier.issn | 20402503 | |
dc.identifier.other | 2-s2.0-82455186221 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/14449 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-82455186221&doi=10.1039%2fc1md00162k&partnerID=40&md5=f5396527d4ea290686b48e2572eafa0a | |
dc.description.abstract | Two-layered ONIOM calculations were performed in order to compare the binding of efavirenz (EFV) to the HIV-1 RT binding pocket of both wild type (WT) and K103N enzymes. The K103N mutation reduces the binding affinity of the inhibitor by 5.81 kcal mol -1 as obtained from the ONIOM2 (B3LYP/6-31G(d,p):PM3) method. These indicate that the loss of binding energy to K103N mutation can attribute to a weakened attractive interaction between the drug and residues surrounding in the binding pocket. The deformation of the K103N binding pocket requires more energy for structural rearrangement than that of the WT by approximately 4.0 kcal mol -1. Moreover, the pairwise energies perfectly demonstrate that the K103N mutation affects on the loss of the interaction energy. In addition, the main influences are due to residues surrounding in the binding pocket; K101, K102, S105, V179, W229, P236 and E138. In particular, two residues; K101 and S105, established hydrogen bondings with the inhibitor. ONIOM calculations, resulting in the details of binding energy, interaction energy and deformation energy can be used to identify the key interaction and structural requirements of more potent HIV-1 RT inhibitor. © 2011 The Royal Society of Chemistry. | |
dc.subject | efavirenz | |
dc.subject | RNA directed DNA polymerase | |
dc.subject | amino acid sequence | |
dc.subject | article | |
dc.subject | binding affinity | |
dc.subject | binding kinetics | |
dc.subject | binding site | |
dc.subject | drug interaction | |
dc.subject | drug protein binding | |
dc.subject | energy | |
dc.subject | enzyme structure | |
dc.subject | hydrogen bond | |
dc.subject | mathematical analysis | |
dc.subject | mutant | |
dc.subject | priority journal | |
dc.subject | wild type | |
dc.title | Key interactions of the mutant HIV-1 reverse transcriptase/efavirenz: An evidence obtained from ONIOM method | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | MedChemComm. Vol 2, No.12 (2011), p.1181-1187 | |
dc.identifier.doi | 10.1039/c1md00162k | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.